Jenice Quiogue

How Real Leaders Help Their People Grow Professionally and As a Person

by
Picture shows: How Real Leaders Help Their People Grow Professionally and As a Person

Introduction to Episode: “How Real Leaders Help Their People Grow Professionally and Personally”

What does it take to be a great leader?

How do you build trust, inspire growth, and create real value for your team and organization?

In this episode of The Effective Statistician, I sit down with Aziza Yormirzaeva and Klaus Breuer to answer these questions. Aziza shares how Klaus, her former manager, guided her to discover her passion for statistics and grow both as a professional and as a person. Klaus explains how he empowers his team, fosters trust, and creates a workplace culture that prioritizes learning and collaboration.

Their story is filled with practical lessons, inspiring moments, and insights that will challenge how you think about leadership and personal growth.

Let’s jump right into this fascinating conversation!

Weiterlesen …

Dr. Alexander Schacht

All Episodes

Introduction to Episode: “How Real Leaders Help Their People Grow Professionally and Personally”

What does it take to be a great leader?

How do you build trust, inspire growth, and create real value for your team and organization?

In this episode of The Effective Statistician, I sit down with Aziza Yormirzaeva and Klaus Breuer to answer these questions. Aziza shares how Klaus, her former manager, guided her to discover her passion for statistics and grow both as a professional and as a person. Klaus explains how he empowers his team, fosters trust, and creates a workplace culture that prioritizes learning and collaboration.

Their story is filled with practical lessons, inspiring moments, and insights that will challenge how you think about leadership and personal growth.

Let’s jump right into this fascinating conversation!

Weiterlesen …

How Real Leaders Help Their People Grow Professionally and As a Person

Dr. Alexander Schacht

All Episodes

Introduction to Episode: “How Real Leaders Help Their People Grow Professionally and Personally”

What does it take to be a great leader?

How do you build trust, inspire growth, and create real value for your team and organization?

In this episode of The Effective Statistician, I sit down with Aziza Yormirzaeva and Klaus Breuer to answer these questions. Aziza shares how Klaus, her former manager, guided her to discover her passion for statistics and grow both as a professional and as a person. Klaus explains how he empowers his team, fosters trust, and creates a workplace culture that prioritizes learning and collaboration.

Their story is filled with practical lessons, inspiring moments, and insights that will challenge how you think about leadership and personal growth.

Let’s jump right into this fascinating conversation!

Weiterlesen …

Clinical Development of Gene Therapies

by
Picture shows: Clinical Development of Gene Therapies

What makes gene therapy so different from traditional drug development?

How do we address safety when each patient only receives a single dose?

And why are statisticians so essential in this process?

In this episode of The Effective Statistician, I sit down with Oscar Segurado, an MD, PhD, an expert in gene and cell therapies, to answer these questions and more. Oscar draws on decades of experience in academia, med tech, and biopharma—including his work on the blockbuster drug Humira—to guide us through the complexities of clinical development in gene therapy. We discuss everything from early clinical trials to commercialization, uncovering the unique challenges of treating rare diseases like hemophilia A and spinal muscular atrophy.

Whether you’re a statistician, data scientist, or just curious about the future of medicine, this episode offers valuable insights into the clinical development of gene therapies and the vital role statisticians play in advancing these groundbreaking treatments.

Weiterlesen …

Dr. Alexander Schacht

All Episodes

What makes gene therapy so different from traditional drug development?

How do we address safety when each patient only receives a single dose?

And why are statisticians so essential in this process?

In this episode of The Effective Statistician, I sit down with Oscar Segurado, an MD, PhD, an expert in gene and cell therapies, to answer these questions and more. Oscar draws on decades of experience in academia, med tech, and biopharma—including his work on the blockbuster drug Humira—to guide us through the complexities of clinical development in gene therapy. We discuss everything from early clinical trials to commercialization, uncovering the unique challenges of treating rare diseases like hemophilia A and spinal muscular atrophy.

Whether you’re a statistician, data scientist, or just curious about the future of medicine, this episode offers valuable insights into the clinical development of gene therapies and the vital role statisticians play in advancing these groundbreaking treatments.

Weiterlesen …

Clinical Development of Gene Therapies

Dr. Alexander Schacht

All Episodes

What makes gene therapy so different from traditional drug development?

How do we address safety when each patient only receives a single dose?

And why are statisticians so essential in this process?

In this episode of The Effective Statistician, I sit down with Oscar Segurado, an MD, PhD, an expert in gene and cell therapies, to answer these questions and more. Oscar draws on decades of experience in academia, med tech, and biopharma—including his work on the blockbuster drug Humira—to guide us through the complexities of clinical development in gene therapy. We discuss everything from early clinical trials to commercialization, uncovering the unique challenges of treating rare diseases like hemophilia A and spinal muscular atrophy.

Whether you’re a statistician, data scientist, or just curious about the future of medicine, this episode offers valuable insights into the clinical development of gene therapies and the vital role statisticians play in advancing these groundbreaking treatments.

Weiterlesen …

Statistical Topics in Gene Therapy

by
Picture shows: Statistical Topics in Gene Therapy

What if we could target genetic diseases at their root, offering lifelong cures instead of temporary solutions?

And what role do statisticians play in making this breakthrough possible?

In this episode of The Effective Statistician, I dive into the fascinating world of gene therapy—an area packed with both promise and complexity.

I’m thrilled to finally cover this revolutionary field with two expert guests, Avery McIntosh from Pfizer and Alex Sverdlov from Novartis. Together, we break down the science behind gene therapies, explore the ethical and logistical challenges, and reveal how statisticians drive these life-changing treatments forward.

So, how close are we to curing diseases through gene therapy? Let’s jump in and find out.

Weiterlesen …

Dr. Alexander Schacht

All Episodes

What if we could target genetic diseases at their root, offering lifelong cures instead of temporary solutions?

And what role do statisticians play in making this breakthrough possible?

In this episode of The Effective Statistician, I dive into the fascinating world of gene therapy—an area packed with both promise and complexity.

I’m thrilled to finally cover this revolutionary field with two expert guests, Avery McIntosh from Pfizer and Alex Sverdlov from Novartis. Together, we break down the science behind gene therapies, explore the ethical and logistical challenges, and reveal how statisticians drive these life-changing treatments forward.

So, how close are we to curing diseases through gene therapy? Let’s jump in and find out.

Weiterlesen …

Statistical Topics in Gene Therapy

Dr. Alexander Schacht

All Episodes

What if we could target genetic diseases at their root, offering lifelong cures instead of temporary solutions?

And what role do statisticians play in making this breakthrough possible?

In this episode of The Effective Statistician, I dive into the fascinating world of gene therapy—an area packed with both promise and complexity.

I’m thrilled to finally cover this revolutionary field with two expert guests, Avery McIntosh from Pfizer and Alex Sverdlov from Novartis. Together, we break down the science behind gene therapies, explore the ethical and logistical challenges, and reveal how statisticians drive these life-changing treatments forward.

So, how close are we to curing diseases through gene therapy? Let’s jump in and find out.

Weiterlesen …

Clinical Development Plans

by
Picture shows: Clinical Development Plans

What does it take to create an effective clinical development plan? How do our early decisions shape the path of a compound through clinical phases? And how can statisticians actively balance the demands of science, speed, and cost in drug development?

In this special 400th episode of The Effective Statistician, I dive into these questions with Carrie Li, a biostatistics expert whose career spans both big pharma and startups. Carrie shares how she builds clinical development plans from scratch, collaborates with cross-functional teams, and uses statistical expertise to create strategies that drive both scientific and commercial success.

Join us as we explore the impact statisticians have on the clinical development journey.

Weiterlesen …

Dr. Alexander Schacht

All Episodes

What does it take to create an effective clinical development plan? How do our early decisions shape the path of a compound through clinical phases? And how can statisticians actively balance the demands of science, speed, and cost in drug development?

In this special 400th episode of The Effective Statistician, I dive into these questions with Carrie Li, a biostatistics expert whose career spans both big pharma and startups. Carrie shares how she builds clinical development plans from scratch, collaborates with cross-functional teams, and uses statistical expertise to create strategies that drive both scientific and commercial success.

Join us as we explore the impact statisticians have on the clinical development journey.

Weiterlesen …

Clinical Development Plans

Dr. Alexander Schacht

All Episodes

What does it take to create an effective clinical development plan? How do our early decisions shape the path of a compound through clinical phases? And how can statisticians actively balance the demands of science, speed, and cost in drug development?

In this special 400th episode of The Effective Statistician, I dive into these questions with Carrie Li, a biostatistics expert whose career spans both big pharma and startups. Carrie shares how she builds clinical development plans from scratch, collaborates with cross-functional teams, and uses statistical expertise to create strategies that drive both scientific and commercial success.

Join us as we explore the impact statisticians have on the clinical development journey.

Weiterlesen …

The Most Important Things You Need to Know About AI And ML

by
Picture shows: The Most Important Things You Need to Know About AI And ML

Have you wondered how large language models (LLMs) like ChatGPT are transforming the way we work?

How can AI tools boost efficiency in statistics and pharmaceutical research?

In this episode of The Effective Statistician, I talk with Pietro Mascheroni from Boehringer Ingelheim to answer these questions. Pietro, a physicist, shares how LLMs are being used in real-world applications, from simplifying document retrieval to enhancing data exploration and refining code.

We dive into why it’s crucial to maintain human oversight, how AI can improve team communication, and the challenges in validating these models.

If you’re eager to learn how AI can revolutionize your work or help you stay ahead in this fast-paced field, tune in to this insightful episode!

Weiterlesen …

Dr. Alexander Schacht

All Episodes

Have you wondered how large language models (LLMs) like ChatGPT are transforming the way we work?

How can AI tools boost efficiency in statistics and pharmaceutical research?

In this episode of The Effective Statistician, I talk with Pietro Mascheroni from Boehringer Ingelheim to answer these questions. Pietro, a physicist, shares how LLMs are being used in real-world applications, from simplifying document retrieval to enhancing data exploration and refining code.

We dive into why it’s crucial to maintain human oversight, how AI can improve team communication, and the challenges in validating these models.

If you’re eager to learn how AI can revolutionize your work or help you stay ahead in this fast-paced field, tune in to this insightful episode!

Weiterlesen …

The Most Important Things You Need to Know About AI And ML

Dr. Alexander Schacht

All Episodes

Have you wondered how large language models (LLMs) like ChatGPT are transforming the way we work?

How can AI tools boost efficiency in statistics and pharmaceutical research?

In this episode of The Effective Statistician, I talk with Pietro Mascheroni from Boehringer Ingelheim to answer these questions. Pietro, a physicist, shares how LLMs are being used in real-world applications, from simplifying document retrieval to enhancing data exploration and refining code.

We dive into why it’s crucial to maintain human oversight, how AI can improve team communication, and the challenges in validating these models.

If you’re eager to learn how AI can revolutionize your work or help you stay ahead in this fast-paced field, tune in to this insightful episode!

Weiterlesen …

Overcoming Challenges of Working Effectively Together: Pharma And Small Providers

by
Picture shows: Overcoming Challenges of Working Effectively Together: Pharma And Small Providers

Today, we’re diving into some intriguing questions:

How can big pharmaceutical companies and small providers work together more effectively?

What hidden costs and inefficiencies are lurking in traditional outsourcing models?

And how can innovative solutions transform these dynamics?

I’m joined by Sheila Mahoney, a seasoned drug development expert with over 25 years of experience. Sheila introduced us to LifeSciHub, a platform designed to streamline contracting processes and enhance collaboration.

Together, we explore how LifeSciHub’s approach not only improves cost-effectiveness but also ensures access to top-tier expertise. 

Join us as we uncover new ways to optimize pharma collaborations for better outcomes.

Weiterlesen …

Dr. Alexander Schacht

All Episodes

Today, we’re diving into some intriguing questions:

How can big pharmaceutical companies and small providers work together more effectively?

What hidden costs and inefficiencies are lurking in traditional outsourcing models?

And how can innovative solutions transform these dynamics?

I’m joined by Sheila Mahoney, a seasoned drug development expert with over 25 years of experience. Sheila introduced us to LifeSciHub, a platform designed to streamline contracting processes and enhance collaboration.

Together, we explore how LifeSciHub’s approach not only improves cost-effectiveness but also ensures access to top-tier expertise. 

Join us as we uncover new ways to optimize pharma collaborations for better outcomes.

Weiterlesen …

Overcoming Challenges of Working Effectively Together: Pharma And Small Providers

Dr. Alexander Schacht

All Episodes

Today, we’re diving into some intriguing questions:

How can big pharmaceutical companies and small providers work together more effectively?

What hidden costs and inefficiencies are lurking in traditional outsourcing models?

And how can innovative solutions transform these dynamics?

I’m joined by Sheila Mahoney, a seasoned drug development expert with over 25 years of experience. Sheila introduced us to LifeSciHub, a platform designed to streamline contracting processes and enhance collaboration.

Together, we explore how LifeSciHub’s approach not only improves cost-effectiveness but also ensures access to top-tier expertise. 

Join us as we uncover new ways to optimize pharma collaborations for better outcomes.

Weiterlesen …

Digital Transformation And Innovation (Part 2)

by

In this exciting continuation of our series on digital transformation and innovation, we dive deeper into the crucial role of policies in driving successful change.

I’m joined once again by Chris Colangelo, who brings his extensive experience from working closely with IT and digital teams.

In this episode, we examine how companies often overlook strategic policies and the implications of build versus buy decisions. Chris shares his insights on aligning technology strategies with business objectives and navigating the complexities of organizational change.

Join us as we explore these essential aspects and provide actionable advice to help you lead effective digital transformation in your organization.

Here is Part 1 of this series.

Weiterlesen …

Dr. Alexander Schacht

All Episodes

In this exciting continuation of our series on digital transformation and innovation, we dive deeper into the crucial role of policies in driving successful change.

I’m joined once again by Chris Colangelo, who brings his extensive experience from working closely with IT and digital teams.

In this episode, we examine how companies often overlook strategic policies and the implications of build versus buy decisions. Chris shares his insights on aligning technology strategies with business objectives and navigating the complexities of organizational change.

Join us as we explore these essential aspects and provide actionable advice to help you lead effective digital transformation in your organization.

Here is Part 1 of this series.

Weiterlesen …

Digital Transformation And Innovation (Part 2)

Dr. Alexander Schacht

All Episodes

In this exciting continuation of our series on digital transformation and innovation, we dive deeper into the crucial role of policies in driving successful change.

I’m joined once again by Chris Colangelo, who brings his extensive experience from working closely with IT and digital teams.

In this episode, we examine how companies often overlook strategic policies and the implications of build versus buy decisions. Chris shares his insights on aligning technology strategies with business objectives and navigating the complexities of organizational change.

Join us as we explore these essential aspects and provide actionable advice to help you lead effective digital transformation in your organization.

Here is Part 1 of this series.

Weiterlesen …

Digital Transformation And Innovation (Part 1)

by

Have you ever wondered why some digital transformation efforts fail miserably while others succeed brilliantly?

Are you curious about the key elements that can make or break innovation in your organization? 

Today, I explore these questions with my former colleague and friend, Chris Colangelo. With extensive experience in digital transformation at Eli Lilly and Pfizer, Chris now leads his own consultancy, Colangelo Advisory Group.

In this episode, we uncover the critical mistakes to avoid and the strategies to embrace for successful innovation and transformation. From understanding the importance of mindset and managing emotions to navigating policies and effective communication, Chris shares invaluable insights for statisticians looking to drive meaningful change.

Let’s dive in and discover how to turn digital transformation challenges into opportunities!

Weiterlesen …

Dr. Alexander Schacht

All Episodes

Have you ever wondered why some digital transformation efforts fail miserably while others succeed brilliantly?

Are you curious about the key elements that can make or break innovation in your organization? 

Today, I explore these questions with my former colleague and friend, Chris Colangelo. With extensive experience in digital transformation at Eli Lilly and Pfizer, Chris now leads his own consultancy, Colangelo Advisory Group.

In this episode, we uncover the critical mistakes to avoid and the strategies to embrace for successful innovation and transformation. From understanding the importance of mindset and managing emotions to navigating policies and effective communication, Chris shares invaluable insights for statisticians looking to drive meaningful change.

Let’s dive in and discover how to turn digital transformation challenges into opportunities!

Weiterlesen …

Digital Transformation And Innovation (Part 1)

Dr. Alexander Schacht

All Episodes

Have you ever wondered why some digital transformation efforts fail miserably while others succeed brilliantly?

Are you curious about the key elements that can make or break innovation in your organization? 

Today, I explore these questions with my former colleague and friend, Chris Colangelo. With extensive experience in digital transformation at Eli Lilly and Pfizer, Chris now leads his own consultancy, Colangelo Advisory Group.

In this episode, we uncover the critical mistakes to avoid and the strategies to embrace for successful innovation and transformation. From understanding the importance of mindset and managing emotions to navigating policies and effective communication, Chris shares invaluable insights for statisticians looking to drive meaningful change.

Let’s dive in and discover how to turn digital transformation challenges into opportunities!

Weiterlesen …

The Role Of Coaching For Your Career And Success

by
Picture shows: The Role Of Coaching For Your Career And Success

Have you ever wondered how coaching can impact your career and success?

Are you curious about the differences between coaching and mentoring and how each can benefit you?

In this episode, I explore these questions with Alun Bedding, a seasoned statistician who has recently ventured into the world of coaching. I’m thrilled to welcome Alun back to the show. He shares his inspiring journey from taking leadership courses to launching his own coaching business. We explore the value of having a coach, the transformative power of effective coaching practices, and practical advice for enhancing your professional skills.

Whether you want to gain new perspectives or unlock your potential, this episode offers valuable insights for statisticians and professionals alike. Join us as we uncover how coaching can propel you toward greater achievements.

Weiterlesen …

Dr. Alexander Schacht

All Episodes

Have you ever wondered how coaching can impact your career and success?

Are you curious about the differences between coaching and mentoring and how each can benefit you?

In this episode, I explore these questions with Alun Bedding, a seasoned statistician who has recently ventured into the world of coaching. I’m thrilled to welcome Alun back to the show. He shares his inspiring journey from taking leadership courses to launching his own coaching business. We explore the value of having a coach, the transformative power of effective coaching practices, and practical advice for enhancing your professional skills.

Whether you want to gain new perspectives or unlock your potential, this episode offers valuable insights for statisticians and professionals alike. Join us as we uncover how coaching can propel you toward greater achievements.

Weiterlesen …

The Role Of Coaching For Your Career And Success

Dr. Alexander Schacht

All Episodes

Have you ever wondered how coaching can impact your career and success?

Are you curious about the differences between coaching and mentoring and how each can benefit you?

In this episode, I explore these questions with Alun Bedding, a seasoned statistician who has recently ventured into the world of coaching. I’m thrilled to welcome Alun back to the show. He shares his inspiring journey from taking leadership courses to launching his own coaching business. We explore the value of having a coach, the transformative power of effective coaching practices, and practical advice for enhancing your professional skills.

Whether you want to gain new perspectives or unlock your potential, this episode offers valuable insights for statisticians and professionals alike. Join us as we uncover how coaching can propel you toward greater achievements.

Weiterlesen …

Benefit-Risk

by
Picture show: Benefit-risk

Are you curious about how benefit-risk assessments in healthcare evolve?

Do you wonder how patient preferences shape these evaluations?

Today, I speak with Tommi Tervonen, a leading expert in this field, to answer these questions and more. Tommi, the Chief Scientist at Kielo Research in Zurich, brings nearly two decades of experience in Multi-Criteria Decision Analysis (MCDA), patient preferences, and benefit-risk evaluations.

This episode sheds light on the past, present, and future of benefit-risk assessments and shows how incorporating patient input is transforming healthcare decisions. Join us as we dive deep into this fascinating topic and discover the importance of structured methodologies and patient-centric approaches in making informed healthcare choices.

Key Points:
  • Benefit-risk assessments: Evolution in healthcare evaluations.
  • Patient preferences: Importance in benefit-risk evaluations.

Weiterlesen …

Dr. Alexander Schacht

All Episodes

Are you curious about how benefit-risk assessments in healthcare evolve?

Do you wonder how patient preferences shape these evaluations?

Today, I speak with Tommi Tervonen, a leading expert in this field, to answer these questions and more. Tommi, the Chief Scientist at Kielo Research in Zurich, brings nearly two decades of experience in Multi-Criteria Decision Analysis (MCDA), patient preferences, and benefit-risk evaluations.

This episode sheds light on the past, present, and future of benefit-risk assessments and shows how incorporating patient input is transforming healthcare decisions. Join us as we dive deep into this fascinating topic and discover the importance of structured methodologies and patient-centric approaches in making informed healthcare choices.

Key Points:
  • Benefit-risk assessments: Evolution in healthcare evaluations.
  • Patient preferences: Importance in benefit-risk evaluations.

Weiterlesen …

Benefit-Risk

Dr. Alexander Schacht

All Episodes

Are you curious about how benefit-risk assessments in healthcare evolve?

Do you wonder how patient preferences shape these evaluations?

Today, I speak with Tommi Tervonen, a leading expert in this field, to answer these questions and more. Tommi, the Chief Scientist at Kielo Research in Zurich, brings nearly two decades of experience in Multi-Criteria Decision Analysis (MCDA), patient preferences, and benefit-risk evaluations.

This episode sheds light on the past, present, and future of benefit-risk assessments and shows how incorporating patient input is transforming healthcare decisions. Join us as we dive deep into this fascinating topic and discover the importance of structured methodologies and patient-centric approaches in making informed healthcare choices.

Key Points:
  • Benefit-risk assessments: Evolution in healthcare evaluations.
  • Patient preferences: Importance in benefit-risk evaluations.

Weiterlesen …